Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 866

1.

Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.

Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):681-7.

2.

Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.

Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1053-60.

3.

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.

Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG.

Am J Epidemiol. 2000 Apr 1;151(7):703-14.

PMID:
10752798
4.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
5.

Risk factors for breast cancer according to estrogen and progesterone receptor status.

Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

PMID:
14759989
6.

Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.

Arch Intern Med. 2006 Dec 11-25;166(22):2478-83.

PMID:
17159013
7.

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.

Vrieling A, Buck K, Kaaks R, Chang-Claude J.

Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Review.

PMID:
20711809
8.

Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).

Yoo K, Tajima K, Park S, Kang D, Kim S, Hirose K, Takeuchi T, Miura S.

Cancer Lett. 2001 Jun 10;167(1):57-63.

PMID:
11323099
9.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

10.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

11.

Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.

Fagherazzi G, Chabbert-Buffet N, Fabre A, Guillas G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Int J Obes (Lond). 2012 Mar;36(3):431-9. doi: 10.1038/ijo.2011.66. Epub 2011 Mar 22.

PMID:
21427693
12.

Relation between steroid receptor status and body weight in breast cancer patients.

Giuffrida D, Lupo L, La Porta GA, La Rosa GL, Padova G, Foti E, Marchese V, Belfiore A.

Eur J Cancer. 1992;28(1):112-5.

PMID:
1567660
13.

Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women.

Wenten M, Gilliland FD, Baumgartner K, Samet JM.

Ann Epidemiol. 2002 Aug;12(6):435-4.

PMID:
12160603
14.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
15.

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.

Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA.

Am J Epidemiol. 2002 Sep 15;156(6):507-16.

PMID:
12225998
16.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
17.

Lifetime recreational exercise activity and breast cancer risk among black women and white women.

Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR, McDonald JA, Norman SA, Malone KE, Strom BL, Liff J, Folger SG, Simon MS, Burkman RT, Marchbanks PA, Weiss LK, Spirtas R.

J Natl Cancer Inst. 2005 Nov 16;97(22):1671-9.

PMID:
16288120
18.

Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.

Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A.

Cancer. 1989 Jul 1;64(1):196-202.

19.

Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.

Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):41-7.

20.

Energy balance and breast cancer risk: a prospective cohort study.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE.

Breast Cancer Res Treat. 2006 May;97(1):97-106. Epub 2005 Dec 1.

PMID:
16319973

Supplemental Content

Support Center